Anxiety and depression · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Severity of PTSD symptoms · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Physical function · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Cognitive function · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Ability to return to work or education (reported at 12 months) · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Adverse effects · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease-free survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Swallowing ability · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Voice (Voice Handicap Index) · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease-free survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Swallowing ability · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Voice (Voice Handicap Index) · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total mortality
Beta‐blockers showed no clear difference in total mortality compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events
Beta‐blockers showed no clear difference in withdrawal due to adverse effect compared with diuretics (low certainty).
1 finding from 1 review
Total mortality
Beta‐blockers showed no clear difference in total mortality compared with calcium‐channel blockers (moderate certainty).
1 finding from 1 review
Total cardiovascular disease
Beta‐blockers probably leads to higher total cardiovascular disease compared with calcium‐channel blockers (moderate certainty).
1 finding from 1 review
Stroke
Beta‐blockers probably leads to higher total stroke compared with calcium‐channel blockers (moderate certainty).
1 finding from 1 review
Total coronary heart disease
Beta‐blockers showed no clear difference in total coronary heart disease compared with calcium‐channel blockers (moderate certainty).
1 finding from 1 review